Autor: |
I P, Gorbarets, E S, Ketiladze, N A, Farber, N P, Bugaeva, D M, Braginskiĭ |
Rok vydání: |
1990 |
Předmět: |
|
Zdroj: |
Klinicheskaia meditsina. 68(3) |
ISSN: |
0023-2149 |
Popis: |
Clinical, biochemical and serological examinations of 412 patients with acute HBsAg-positive virus hepatitis were conducted to assess therapeutic efficacy of Soviet recombinant alpha 2-interferon (reaferon). There were 309 cases of acute virus hepatitis B, 103 of delta infection (71--coinfection, 32--superinfection). The study and control groups were assigned randomly. Reaferon i.m. administration started on jaundice day 1-5 and lasted for 10-11 days. The treatment proved effective in acute hepatitis B running a moderately severe and severe course up to the development of acute hepatic encephalopathy. In delta infection reaferon produced response in coinfection only. In fulminant hepatitis the treatment was uneffective. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|